Aboleris Aboleris Pharma is a preclinical stage company, developing novel and unique therapeutic approaches to induce immune tolerance while preserving useful immune responses; with the aim to address signifi ...
Artax Biopharma Artax Biopharma is a clinical stage biotechnology company that develops novel treatments for autoimmune diseases. The lead product, AX-158, is a first-in-class, oral small molecule that inhibits N ...
Arthex ARTHEx Biotech is a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs. The Company’s lead investigational compound, ATX-01, is advanc ...
Breye Therapeutics Breye Therapeutics is a clinical development stage company that developing new therapies within Opthalmology The lead program is Danegaptide – an oral drug that can both treat Diabetic Retinopathy ...
NephroDI NephroDI is a pre-clinical stage company developing an oral small molecule drug for genetic (X-Linked) and drug induced (Tolvaptan and Lithium induced) Nephrogenic Diabetes Insipidus (NDI). The compo ...
Teitur Teitur is a preclinical stage company, developing novel therapeutics for treating neurodegenerative diseases, including Huntington’s Disease, Parkinson’s Disease and Frontotemporal Dementia. The lead ...
Theolytics Theolytics is a preclinical stage company, developing a new generation of oncolytic viruses for intravenous administration. The ability to specifically target tumour cells and the tumour micro-enviro ...
VarmX VarmX is a clinical stage company developing drugs that reverse the action of direct acting oral anticoagulants (DOACs).The lead program is a recombinant protein, VMX-C001, that addresses the need of ...
